See more : Karat Packaging Inc. (KRT) Income Statement Analysis – Financial Results
Complete financial analysis of iAnthus Capital Holdings, Inc. (ITHUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of iAnthus Capital Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Oshidori International Holdings Limited (0622.HK) Income Statement Analysis – Financial Results
- Kimco Realty Corporation (KIM-PN) Income Statement Analysis – Financial Results
- TVS Holdings Limited (TVSHLTD.NS) Income Statement Analysis – Financial Results
- Aesthetic Medical International Holdings Group Limited (AIH) Income Statement Analysis – Financial Results
- ams-OSRAM AG (AUKUF) Income Statement Analysis – Financial Results
iAnthus Capital Holdings, Inc. (ITHUF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ianthus.com
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 159.24M | 163.21M | 203.02M | 151.67M | 78.38M | 3.41M | 2.41M | 391.65K | 45.57K | 0.00 |
Cost of Revenue | 96.07M | 88.78M | 91.74M | 64.99M | 38.52M | 6.19M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 63.17M | 74.43M | 111.28M | 86.68M | 39.87M | -2.78M | 2.41M | 391.65K | 45.57K | 0.00 |
Gross Profit Ratio | 39.67% | 45.60% | 54.81% | 57.15% | 50.86% | -81.69% | 100.00% | 100.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 73.17M | 107.59M | 90.32M | 0.00 | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 998.17K |
Selling & Marketing | 4.35M | 4.80M | 4.54M | 0.00 | 5.14M | 0.00 | 0.00 | 0.00 | 0.00 | 5.12K |
SG&A | 78.01M | 112.39M | 96.97M | 109.04M | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 1.56M |
Other Expenses | 25.87M | 32.26M | 30.52M | 29.30M | 23.63M | 6.35M | -17.63K | -200.81K | 0.00 | 0.00 |
Operating Expenses | 103.88M | 144.65M | 127.48M | 138.33M | 114.45M | 41.87M | 9.96M | 4.03M | 1.36M | 1.56M |
Cost & Expenses | 199.15M | 233.43M | 219.22M | 203.32M | 152.97M | 35.69M | 9.96M | 4.03M | 1.36M | 1.56M |
Interest Income | 1.85M | 86.00K | 517.00K | 403.00K | 75.72K | 566.87K | 1.98M | 306.47K | 21.22K | 0.00 |
Interest Expense | 30.16M | 22.25M | 32.67M | 37.65M | 25.25M | 20.93M | 2.49M | 290.82K | 0.00 | 0.00 |
Depreciation & Amortization | 27.17M | 30.15M | 30.77M | 29.39M | 23.01M | 6.03M | 149.37K | 7.65K | 1.32M | 1.56M |
EBITDA | -13.30M | -369.80M | 7.89M | -241.27M | -273.12M | -32.97M | -11.48M | -4.70M | 0.00 | -1.06K |
EBITDA Ratio | -8.35% | -15.33% | 8.34% | -14.84% | -64.90% | -742.86% | -316.51% | -1,149.35% | -2,887.57% | 0.00% |
Operating Income | -40.71M | -70.22M | -14.11M | -51.65M | -74.50M | -31.65M | -7.55M | -3.64M | -1.32M | -1.56M |
Operating Income Ratio | -25.57% | -43.02% | -6.95% | -34.06% | -95.05% | -929.31% | -313.62% | -928.56% | -2,887.57% | 0.00% |
Total Other Income/Expenses | -19.21M | -326.25M | -31.48M | -49.68M | 12.59M | -21.28M | -4.04M | -1.42M | 0.00 | -1.06K |
Income Before Tax | -59.92M | -438.70M | -54.00M | -290.07M | -304.28M | -62.03M | -13.72M | -5.06M | -1.32M | -1.56M |
Income Before Tax Ratio | -37.63% | -268.79% | -26.60% | -191.25% | -388.20% | -1,821.51% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
Income Tax Expense | 16.70M | 10.69M | 22.25M | 19.96M | -3.03M | 9.45M | 2.27M | 326.94K | -1.32M | -1.06K |
Net Income | -76.62M | -449.39M | -76.25M | -310.03M | -301.25M | -71.48M | -13.72M | -5.06M | -1.32M | -1.56M |
Net Income Ratio | -48.12% | -275.34% | -37.56% | -204.41% | -384.34% | -2,098.96% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
EPS | -0.01 | -0.07 | -0.44 | -1.81 | -1.90 | -1.12 | -0.48 | -0.32 | -0.08 | -0.16 |
EPS Diluted | -0.01 | -0.07 | -0.44 | -1.81 | -1.90 | -1.12 | -0.48 | -0.32 | -0.08 | -0.16 |
Weighted Avg Shares Out | 6.44B | 6.40B | 171.72M | 171.65M | 158.21M | 63.86M | 28.58M | 15.80M | 16.95M | 9.78M |
Weighted Avg Shares Out (Dil) | 6.44B | 6.40B | 171.72M | 171.65M | 158.21M | 63.86M | 28.61M | 15.98M | 16.95M | 10.00M |
iAnthus Provides Update to Litigation Claim
iAnthus Reports Third Quarter 2024 Financial Results
iAnthus Reports Second Quarter 2024 Financial Results
iAnthus Announces Results from Annual General and Special Meeting
iAnthus Debuts New GrowHealthy Open Concept Store at North Port, Florida Dispensary Grand Opening
iAnthus Reports First Quarter 2024 Financial Results
Levi & Korsinsky, LLP Notifies Shareholders of iAnthus Capital Holdings, Inc. (ITHUF) an Upcoming Claims Deadline in a Class Action Settlement
Levi & Korsinsky, LLP Notifies Shareholders of iAnthus Capital Holdings, Inc. (ITHUF) an Upcoming Claims Deadline in a Class Action Settlement
Levi & Korsinsky, LLP Notifies Shareholders of iAnthus Capital Holdings, Inc. (ITHUF) an Upcoming Claims Deadline in a Class Action Settlement
iAnthus Announces Strategic Partnership with Timeless Vapes to Bring a Leading Lifestyle Brand to New Jersey
Source: https://incomestatements.info
Category: Stock Reports